BlossomHill Therapeutics (BLSM) prices IPO at $16, raising $150M
As seen on the 24/7 Wall St. homepage on August 7, 2026.
Priced at $16 for a $150M Nasdaq debut
BlossomHill Therapeutics priced its IPO at $16 a share, raising $150 million with J.P. Morgan and Leerink leading the book. A deal that size for a precision oncology developer is a real test of how far the reopened biotech window extends.
Continue ReadingShow less
BlossomHill Therapeutics sold 9,375,000 shares at $16 each in its Nasdaq debut, bringing in $150 million in a deal led by J.P. Morgan and Leerink. The two underwriters are a familiar pairing in biotech capital raises, with Leerink's sector-specific focus lending credibility to the book-building process for a precision oncology story.
The $150 million raise is a meaningful data point for the broader biotech IPO market, which has been cautiously reopening after a prolonged drought. A deal of this size for an early-stage oncology developer signals that institutional investors are willing to put real capital behind the right science, but it also sets a high bar for BlossomHill to demonstrate clinical progress once it begins trading under the ticker BLSM.
Disclosure
1 INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA( www.finra.org )/SIPC( www.sipc.org ).2The probability of a member receiving $1,000 is 0.028%. If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Members must fund their account with a minimum of $50.00 to qualify. The probability percentage is subject to decrease. Members are only eligible for the Stock Award promotion upon opening their first brokerage account; subsequent cash brokerage accounts are ineligible for the promo, including for members with multiple accounts. 3Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. 4There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event.
SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now. (Sponsor)
Investors watching the biotech window will want to track how BLSM trades in its first sessions relative to the $16 offer price. Sustained trading above the issue price would reinforce confidence that the window remains open for similarly sized precision medicine deals, while a break below it could prompt underwriters to price future oncology IPOs more conservatively.
Mentioned: BLSM